Brown Advisory Inc Crinetics Pharmaceuticals, Inc. Transaction History

Brown Advisory Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 13, 2022	SELL	$16.49 - $27.64 $26,169 - $43,864	-1,587 Reduced 9.57%	14,998 $280,000
Q2 2022 Aug 02, 2022	BUY	$16.49 - $27.64 $26,169 - $43,864	1,587 Added 10.58%	16,585 $471,000
Q1 2022 Sep 13, 2022	SELL	$17.15 - $28.31 $27,217 - $44,927	-1,587 Reduced 9.57%	14,998 $329,000
Q4 2021 Jan 27, 2022	BUY	$19.35 - $28.41 $320,919 - $471,179	16,585 New	16,585 $471,000

244

78.2M

268K

197K

Ticker CRNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,752,800
Market Cap $2.73B
Description
Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.